2025-01-21

EU HTA Regulation: JCA in Practice – From Procedure to Evidence Generation

Join our experts Chantal W.M. van Gils & Sigrid Klaar on Thursday, 23rd January at 14:00 UK | 15:00 CET | 09:00 EST for the third installment of our webinar series on the European Health Technology Assessment (HTA) regulation.

Starting January 2025, Europe takes a major step toward harmonized clinical assessment. Get ahead of the curve in this third webinar of our HTAR series, focused on practical strategies and evidence planning for the Joint Clinical Assessment (JCA).

What you'll learn:

  • Timeline and procedural requirements
  • New procedural elements
  • Evidence generation strategies aligned with JCA
  • Real-world PICO example

Why Attend?

With EU HTA regulations now in effect, mastering procedural requirements and evidence planning is essential for European market entry. This session offers:

  • Strategic approaches tailored to your needs
  • Real-world examples from industry experts 
Click here to register

Presenters

Chantal Van Gils

Vice President, Evidence & Value

Sigrid Klaar

Medical Advisor & NDA Advisory Board Member

LET’S TALK

You don't have to go it alone!

Our experienced team has been there before, and we're ready to guide you through the unknown. Share your challenges with us, and together, we'll create a plan to efficiently reach your milestones and turn your vision into reality.

Building Better Biotechs

GDPR Consent(Required)
This field is for validation purposes and should be left unchanged.